References
- Jacoby GA, Medeiros AA. More extended-spectrum 13-lactamases. Antimicrob Agents Chemother 1991; 35: 1697-1704.
- Payne D, Amyes SGB. Transferable resistance to extended-spectrum I3-lactams: a major threat or a minor inconvenience? J Antimicrob Chemother 1991; 27: 255–261.
- Sougakoff W, Goussard S, Gerbau G, Courvalin P. Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes. Rev Infect Dis 1988; 1: 879–884.
- Berman S. Epidemiology of acute respiratory infectious in children in developing countries. Rev Infect Dis 1991; 13 (supp 16): S454-62.
- Bawero F. Pneumococcal resistance to I3-lactam antibi-otics: A global geographic overview. Microb Drug Resist 1995; 2: 115–120.
- Osano E, Arakawa Y, Wacharotayankun R, et al. Molecular characterization of an enterobacterial metallo I3-lac-tamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 1994; 38: 71–78.
- Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aerugi-nosa. Antimicrob Agents Chemother 1991; 35: 147–151.
- Redjeb SB, Yaghlane YH, Boujnah A, Philippon A, Labia R. Synergy between clavulanic acid and newer I3-lactams on nine clinical isolates of Klebsiella pneumonia, Escherichia coli and Salmonella typhimurium resistant to third-genera-tion cephalosporins. J Antimicrob Chemother 1988; 21: 263–266.
- Silva J, Aguilar C. I3-Lactamase bioassay: A simplified method to determine extended-spectrum I3-lactamases (ESBL) in enterobacteria. Arch Med Res 1997; 28: 285–287.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacte-ria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards. Villanova. Pa. 1997.
- Silva J, Aguilar C, Becerra Z, Conde C, Garcia R, Fuchs Y. Resistance to broad spectrum cephalosporins har-boured in plasmids among clinical isolates of enterobacteria. Recent Advances in Chemotherapy. Proceedings of 18th International Congress of Chemotherapy. American Society for Microbiology, Washington, D.C. 1993: 505-506.
- Jacoby GA, Carreras I. Activities of I3-lactam antibiotics against Escherichia coli strains producing extended-spectrum I3-lactamases. Antimicrob Agents Chemother 1995; 34: 858–862.
- Jett BD, Ritchie DJ, Reichley R, Baileym TC, Sahm DF. In vitro activities of various I3-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins. Antimcrob Agents Chemother 1995; 39: 1187–1190.
- Finch RG. Pneumonia: The impact of antibiotic resis-tance on its management. Microb Drug Resist 1995; 1: 149–158.
- Echániz AG, Velázquez MM, Carnalla BN, et al. Antimicrobial susceptibilities and capsular types of invasive Streptococcus pneumoniae isolated in children in Mexico City. Microb Drug Resist 1997; 3: 153–157.
- Spangler SK, Jacobs MR, Appelbaum PC. Susceptibilities of 177 penicillin-susceptible and resistant pneu-mococci to FK 037, cefpirome, cefepime, ceftriaxone, cefo-taxime, ceftazidime, imipenem, biapenem, meropenem and vancomycin. Antimicrob Agents Chemother 1994; 38: 898–900.
- Appelbaum PC. New prospects for antibacterial agents against multidrug-resistant pneumococci. Microb Drug Resist 1995; 1: 43–48.
- Nielsen SV, Henrichsen J. Capsular types of Streptococcus pneumoniae isolated from blood and CSF dur-ing 1982-1987. Clin Infect Dis 1992; 15: 794–798.
- Munoz R, Coffey T, Daniels M, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164: 302–306.
- Leipez-Anturiano FJ, Silva J. Bacterial resistance to antibiotics in acute respiratory infections (ARIs). Arch Med Res 1997; 28 (2): 195–203.